Pfizer says its COVID-19 vaccine protects younger teens
Pfizer says testing trials have shown its COVID-19 vaccine is 100 percent effective in children aged 12 to 15 years old, paving the way for them to seek US emergency use authorization in weeks. The company announced on Wednesday that in a Phase 3 trial of children between the ages of 12 and 15, the … Read more